Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study
Condition(s):Frontal Fibrosing Alopecia; Lichen PlanopilarisLast Updated:January 11, 2024Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Frontal Fibrosing Alopecia; Lichen PlanopilarisLast Updated:January 11, 2024Enrolling by invitation
Condition(s):Efficacy of Tofacitinib in the Systemic SclerosisLast Updated:September 21, 2023Recruiting
Condition(s):Ulcerative ColitisLast Updated:February 13, 2024Recruiting
Condition(s):Alopecia Areata; Alopecia Totalis; Alopecia UniversalisLast Updated:February 26, 2024Completed
Condition(s):Alopecia AreataLast Updated:March 31, 2022Completed
Condition(s):Rheumatoid ArthritisLast Updated:June 15, 2021Unknown status
Condition(s):Axial SpondyloarthritisLast Updated:March 13, 2024Completed
Condition(s):Primary Sjögren’s SyndromeLast Updated:March 2, 2022Unknown status
Condition(s):ANCA Associated Vasculitis; Drug Use; JAK-STAT Pathway DeregulationLast Updated:July 22, 2021Completed
Condition(s):DermatomyositisLast Updated:November 6, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.